The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2008, 180, 4451-4457
Copyright © 2008 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sabatino, J. J.
Right arrow Articles by Evavold, B. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sabatino, J. J., Jr.
Right arrow Articles by Evavold, B. D.

Loss of IFN-{gamma} Enables the Expansion of Autoreactive CD4+ T Cells to Induce Experimental Autoimmune Encephalomyelitis by a Nonencephalitogenic Myelin Variant Antigen1

Joseph J. Sabatino, Jr.*, John Shires{ddagger}, John D. Altman*,{ddagger}, Mandy L. Ford{dagger} and Brian D. Evavold2,*

* Department of Microbiology and Immunology and {dagger} Department of Surgery, Emory University, Atlanta, GA 30322; and {ddagger} Emory Vaccine Research Center, Atlanta, GA 30329

MHC variant peptides are analogues of immunogenic peptides involving alterations of the MHC-binding residues, thereby altering the affinity of the peptide for the MHC molecule. Recently, our laboratory demonstrated that immunization of WT B6 mice with 45D, a low-affinity MHC variant peptide of MOG35–55, results in significantly attenuated experimental autoimmune encephalomyelitis (EAE), yet IFN-{gamma} production is comparable to myelin oligodendrocyte glycoprotein (MOG)35–55-immunized mice. In light of these findings, we asked whether IFN-{gamma} was required for the reduced encephalitogenicity of the weak ligand 45D in EAE. In this study, we report that immunization of mice deficient in IFN-{gamma} or its receptor with 45D exhibit significant EAE signs compared with 45D-immunized wild-type B6 mice. Moreover, 45D-immunized IFN-{gamma}–/– and IFN-{gamma}R–/– mice demonstrate MOG tetramer-positive CD4+ T cells within the CNS and display substantial numbers of MOG-specific CD4+ T cells in the periphery. In contrast, wild-type mice immunized with 45D exhibit reduced numbers of MOG-specific CD4+ T cells in the periphery and lack MOG tetramer- positive CD4+ T cells in the CNS. Importantly, the increased encephalitogenicity of 45D in mice lacking IFN-{gamma} or IFN-{gamma}R was not due to deviation toward an enhanced IL-17-secreting phenotype. These findings demonstrate that IFN-{gamma} significantly attenuates the encephalitogenicity of 45D and are the first to highlight the importance of IFN-{gamma} signaling in setting the threshold level of responsiveness of autoreactive CD4+ T cells to weak ligands.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by National Institutes of Health Grant AI056017.

2 Address correspondence and reprint requests to Dr. Brian D. Evavold, Department of Microbiology and Immunology, Emory University, 1510 Clifton Road, Atlanta, GA 30322. E-mail address: evavold{at}microbio.emory.edu

3 Abbreviations used in this paper: EAE, experimental autoimmune encephalomyelitis; APL, altered peptide ligand; MOG, myelin oligodendrocyte glycoprotein; 7-AAD, 7-aminoactinomycin D; LN, lymph node; WT, wild type.




This article has been cited by other articles:


Home page
J. Immunol.Home page
H. A. Wasserman, C. D. Beal, Y. Zhang, N. Jiang, C. Zhu, and B. D. Evavold
MHC Variant Peptide-Mediated Anergy of Encephalitogenic T Cells Requires SHP-1
J. Immunol., November 15, 2008; 181(10): 6843 - 6849.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.